New York lab CEO allegedly billed insurers for $500M in fraudulent COVID test claims

Coronavirus fraud

The chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests, the U.S. Department of Justice (DOJ) said.

Fast Lab CEO Cemhan “Jimmy” Biricik and medical director, Martin Perlin, M.D., created the business and its website in 2021, during the height of the pandemic, and advertised “free” COVID-19 tests.

Fast Lab, based in New York, collected individuals’ insurance information and used it to fraudulently bill private insurers and federal health programs, including Medicare, Medicaid, and TRICARE, for COVID-19 testing that never took place, the DOJ alleged.

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.